Lenvakast-4mg (Lenvatinib Capsule) 4mg

Lenvakast-4mg (Lenvatinib) capsules offer targeted therapy for certain types of cancer. This 4mg oral treatment is designed for convenient home use with a 30-capsule pack. Ideal for patients seeking reliable cancer support with ambient storage needs.

Strength

4mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

BDR Pharmaceuticals Int'l Pvt Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lenvakast-4mg capsules are used to treat specific cancers, including thyroid cancer and advanced kidney cancer. This medication belongs to a class of drugs known as kinase inhibitors, which help slow the growth of cancer cells. It may also be prescribed for other conditions as determined by a healthcare provider.

Side Effects

Lenvakast-4mg capsules work by interfering with signals that promote cancer cell growth. Patients may experience a range of effects as the body adjusts to the medication. Common effects include fatigue, digestive changes, or skin reactions.

Precautions & Warnings

Store Lenvakast-4mg capsules at room temperature, away from moisture and direct light. Keep the medication out of reach of children and pets. Avoid crushing or opening capsules unless instructed by a healthcare professional. Report any unusual symptoms to your doctor promptly.

Avoid Interactions

Lenvakast-4mg may interact with other medications, including blood thinners, certain antibiotics, and herbal supplements. Alcohol and grapefruit products can also affect how this medication works. Always inform your healthcare provider about all medications and supplements you are taking.

References

Frequently Asked Questions

Lenvakast-4mg is primarily used to treat certain types of cancer, including thyroid and advanced kidney cancer.

Store Lenvakast-4mg capsules at room temperature, away from moisture and direct light.

Consult your doctor before taking Lenvakast-4mg with other medications or supplements to avoid potential interactions.

Common effects may include fatigue, digestive changes, or skin reactions as your body adjusts.

This medication should only be used during pregnancy if clearly needed and under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.